These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36610466)

  • 1. Prognostic impact of lipoprotein(a) in patients undergoing percutaneous coronary intervention modified by low density lipoprotein cholesterol.
    Xu N; Yuan D; Yao Y; Jiang L; Xu J; Tang X; Song Y; Gao L; Chen J; Song L; Zhao X; Chen J; Yang Y; Xu B; Gao R; Yuan J
    Clin Chim Acta; 2023 Feb; 540():117217. PubMed ID: 36610466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome.
    Hao Y; Yang Y; Wang Y; Li J
    Curr Med Res Opin; 2022 Oct; 38(10):1663-1672. PubMed ID: 35575139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention.
    Li J; Yan K; Zhu P; Tang X; Yang Y; Gao R; Yuan J; Zhao X
    Clin Cardiol; 2024 Oct; 47(10):e70025. PubMed ID: 39428896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients.
    Yao Y; Liu J; Wang B; Zhou Z; Lu X; Huang Z; Deng J; Yang Y; Tan N; Chen S; Chen J; Liu Y
    Front Cardiovasc Med; 2021; 8():817442. PubMed ID: 35097030
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Rikhi R; Hammoud A; Ashburn N; Snavely AC; Michos ED; Chevli P; Tsai MY; Herrington D; Shapiro MD
    Atherosclerosis; 2022 Dec; 363():102-108. PubMed ID: 36253168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Yuan D; Wang P; Jia S; Zhang C; Zhu P; Jiang L; Liu R; Xu J; Tang X; Song Y; Yao Y; Xu N; Zhang Y; Zhao X; Yang Y; Xu B; Gao L; Gao Z; Gao R; Yuan J
    Atherosclerosis; 2022 Dec; 363():109-116. PubMed ID: 36357218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1670-1680. PubMed ID: 35525680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.
    Gencer B; Rigamonti F; Nanchen D; Vuilleumier N; Kern I; Aghlmandi S; Klingenberg R; Räber L; Auer R; Carballo D; Carballo S; Heg D; Windecker S; Lüscher TF; Matter CM; Rodondi N; Mach F
    Eur J Clin Invest; 2019 Jul; 49(7):e13117. PubMed ID: 30937890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels.
    Zhu L; Zheng J; Gao B; Jin X; He Y; Zhou L; Huang J
    BMC Cardiovasc Disord; 2022 Apr; 22(1):171. PubMed ID: 35428179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.
    Verbeek R; Hoogeveen RM; Langsted A; Stiekema LCA; Verweij SL; Hovingh GK; Wareham NJ; Khaw KT; Boekholdt SM; Nordestgaard BG; Stroes ESG
    Eur Heart J; 2018 Jul; 39(27):2589-2596. PubMed ID: 29931232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels.
    Xu J; Hao X; Zhan R; Jiang X; Jin A; Xue J; Cheng A; Liu J; Lin J; Meng X; Li H; Zheng L; Wang Y
    Stroke; 2022 Aug; 53(8):2504-2511. PubMed ID: 35410491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Nakamura H; Kataoka Y; Nicholls SJ; Puri R; Kitahara S; Murai K; Sawada K; Matama H; Iwai T; Honda S; Fujino M; Takagi K; Yoneda S; Otsuka F; Nishihira K; Asaumi Y; Tsujita K; Noguchi T
    Atherosclerosis; 2022 May; 349():183-189. PubMed ID: 35450750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial.
    Yu Q; Xue Q; Liu H; Hu J; Wang R; Song Y; Zhou Y; Zhang W; Zhu Y; Zhao Q
    Front Cardiovasc Med; 2023; 10():1103681. PubMed ID: 37034344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
    Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
    Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.